Lexicon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $692 | $21,102 | $5,493 | $14,182 |
Gross Profit | 653 | 20,994 | 5,174 | 14,172 |
EBITDA | -29,064 | 657 | -13,381 | -10,463 |
EBIT | -29,166 | 547 | -13,499 | -10,614 |
Net Income | -31,775 | -1,043 | -15,530 | -12,769 |
Net Change In Cash | 692 | 21,102 | 5,493 | 14,182 |
Free Cash Flow | -23,922 | -14,730 | -17,233 | -23,833 |
Cash | 40,924 | 38,089 | 34,326 | 49,656 |
Basic Shares | 437,653 | 400,240 | 363,428 | 363,399 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $49,803 | $31,081 | $1,204 | $139 |
Gross Profit | 49,529 | 30,465 | -57,768 | -52,377 |
EBITDA | -41,381 | -184,290 | -169,756 | -100,033 |
EBIT | -42,002 | -184,824 | -170,310 | -100,460 |
Net Income | -50,341 | -200,403 | -177,119 | -101,944 |
Net Change In Cash | 49,803 | 31,081 | 1,204 | 139 |
Cost of Revenue | -17,720 | |||
Free Cash Flow | -67,851 | -179,811 | -162,367 | -90,177 |
Cash | 34,326 | 66,656 | 22,465 | 46,345 |
Basic Shares | 363,053 | 320,031 | 221,130 | 165,733 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.06 |
2026-03-31 | -$0.002 |
2025-12-31 | -$0.04 |
2025-09-30 | -$0.04 |